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OBJECTIVE — Hypoglycemia unawareness increases severe hypoglycemia risk. Hypoglyce-
mia avoidance restores awareness, but it is difﬁcult to sustain. We compared adherence to
treatment changes by awareness status.
RESEARCH DESIGN AND METHODS — Case notes of 90 type 1 diabetic patients
wereanalyzedretrospectively,identifyingawarenessstatusandinsulinregimensoverfourvisits.
The proportion of patients adhering to advice and percent advice taken were calculated.
RESULTS — A total of 31 patients with hypoglycemia awareness and 19 patients with hypo-
glycemia unawareness were identiﬁed, with insulin regimens available in 23 and 13, respec-
tively. Patients with hypoglycemia unawareness were older (P  0.001) and had longer diabetes
duration (P  0.002) and lower A1C (P  0.007). More patients with hypoglycemia unaware-
ness reported severe hypoglycemia (P  0.002) and fewer were adherent (53.8 vs. 87.0%, P 
0.046), with lower adherence scores (42.5  24.7 vs. 75.3  27.5%, P  0.001).
CONCLUSIONS — Reduced adherence to changes in insulin regimen in hypoglycemia
unawareness is compatible with habituation to hypoglycemic stress. Therapies aimed at revers-
ingrepetitiveharmfulbehaviorsmaybeusefultorestorehypoglycemiaawarenessandprotection
from severe hypoglycemia.
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H
ypoglycemia unawareness in type 1
diabetes increases risk of severe hy-
poglycemia more than ﬁvefold (1).
Hypoglycemia awareness can be restored
by hypoglycemia avoidance (2–4), which
canbedifﬁcult.Wehypothesizedthathy-
poglycemia unawareness may translate
into resistance to changing insulin regi-
mens targeting hypoglycemia avoidance.
RESEARCH DESIGN AND
METHODS— We conducted retro-
spective case-note analysis of 90 consec-
utive patients with type 1 diabetes,
deﬁned by history, attending an intensi-
ﬁed insulin therapy clinic over 3 months.
This was part of a routine clinic perfor-
mance audit; therefore, patient consent
was not required. Patients were excluded
if they had attended fewer than four visits
before the audit or had incomplete notes
(n  19) or had undertaken major regi-
men change by starting pump therapy
(continuous subcutaneous insulin infu-
sion) or attending the structured type 1
diabetes education program Dose Adjust-
ment for Normal Eating (DAFNE) (n 
11) (5) within the audit duration.
Visit date, weight, A1C (high-
performance liquid chromatography as-
say, inter- and intra-assay variation of 1.9
and 1.5, respectively), DAFNE training,
hypoglycemia awareness status, severe hy-
poglycemia episodes (requiring assistance)
sincelastvisit,currentinsulinregimen,and
changes made to it recorded by the clini-
cianateachvisitwerecollectedforthelast
four visits. Hypoglycemia awareness was
deﬁned by the clinicians’ documentation
(6). Hypoglycemia-aware patients had
symptomatic awareness 3.5 mmol/l as
opposed to partially aware patients, who
had inconsistent symptoms, and hypo-
glycemia-unaware patients, who had
minimal or no symptoms 3.0 mmol/l.
Adherence was deﬁned using two meth-
ods. The proportion of agreed changes to
insulin regimen adhered to across visits
one to four was calculated for each set of
consecutive visits (one to two, two to
three, and three to four) and meaned to
one value per patient. Patients scoring
50% were deﬁned as adherent. Adher-
ence scores (percent advice taken) were
also measured. A total of 23 aware pa-
tients and 13 unaware patients had sufﬁ-
cient data for these assessments. Age, sex,
height, psychiatric history, and exposure
to cognitive behavioral therapy were col-
lected from visit 4.
Data were analyzed using 
2 or
Mann-Whitney U test for categorical or
non–normally distributed data; continu-
ous data were tested for normality (Kol-
mogorov-Smirnov) and analyzed with
Student’s independent two-tailed t test.
RESULTS— Of the 60 patients who
mettheinclusioncriteria,10wereexcluded
forpartialawareness,leaving31withhypo-
glycemia awareness and 19 with hypogly-
cemia unawareness (Table 1).
The mean study period for patients
with hypoglycemia unawareness was
shorter than for patients with hypoglyce-
miaawareness,reﬂectingshorterintervals
between scheduled visits. Patients with
hypoglycemia unawareness were older,
withlongerdiabetesduration.Therewere
no signiﬁcant differences between groups
in sex, weight or BMI, proportion previ-
ously attending DAFNE before audit, and
proportion with psychiatric morbidity or
history of previous coincidental cognitive
behavioral therapy.
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tients had lower A1C, despite lower daily
insulin doses. By visit 4, A1C in the hy-
poglycemia-unaware group had risen to
7.8  0.8% (P  0.001). Their insulin
dose remained lower (0.54  0.19 vs.
0.71  0.21 units   kg
1   day
1, P 
0.01). Nine of 17 hypoglycemia-unaware
patients (47.4%) versus three of 31
(9.6%) patients with hypoglycemia
awareness reported one or more severe
episodeofhypoglycemiaduringthestudy
(risk ratio 5.2 [95% CI 1.14–23.3], P 
0.002; median prevalence 71.4 [inter-
quartile range 488.8] and 0.0 [0.0], P 
0.001, per 100 patient-years). No signiﬁ-
cant change occurred in awareness status
over the audit (P  0.644).
A total of 7 of 13 (53.8%) hypoglyce-
mia-unaware patients versus 20 of 23
(87.0%) hypoglycemia-aware patients
were deﬁned as adherent (P  0.046). A
smallerpercentageofadvicewasfollowed
by patients with hypoglycemia unaware-
ness (44.7  19.3% vs. 70.4  28.3%,
P  0.009).
More patients with previous contact
with liaison psychiatry were adherent
(80.7  20.5% vs. 53.7  28.1%, P 
0.022). Adherence was higher in patients
who had experienced cognitive behav-
ioral therapy (80.3  16.5% advice taken
vs. 54.6  28.8%, P  0.042).
CONCLUSIONS— Type 1 diabetic
patients with hypoglycemia unawareness
wereolder,withlongerdiabetesduration,
more severe hypoglycemia, and lower
A1C than patients with hypoglycemia
awareness, consistent with published lit-
erature (7). The novel ﬁnding is that pa-
tients with hypoglycemia unawareness
were signiﬁcantly less adherent to agreed
changestoinsulinregimensthantheirhy-
poglycemia-aware counterparts, in spite
of increased clinical contact. An apparent
lack of beneﬁt of this, with a rise in A1C
and no change in awareness status, could
relate to exclusion of 11 potentially eligi-
blepatientsundertakingmajorchangesto
their diabetes management known to im-
prove A1C and reduce hypoglycemia,
group-structurededucationinﬂexiblein-
sulin therapy, or continuous subcutane-
ous insulin infusion (8,9).
Treatment targets in hypoglycemia
unawareness focus on hypoglycemia
avoidance(3,5),andthelowerA1Cofour
hypoglycemia-unaware group at study
start may have been in part related to
greater exposure to hypoglycemia, a
driver for unawareness. The explicit aim
of treatment adjustments was impossible
to assess from notes, but our data, with a
rise in A1C in hypoglycemia-unaware pa-
tients, argue against beneﬁt of relaxation
of glycemic control alone (rather than hy-
poglycemia avoidance per se) to improve
hypoglycemia awareness (10). Interest-
ingly, patients who had attended coinci-
dental cognitive behavioral therapy had a
higheradherencethanthosewhohadnot,
although numbers were too small to ana-
lyze this by awareness status.
The audit was limited in that it was
retrospective, not blinded, and did not
use formal scoring to deﬁne awareness
(2,11)ordocumentdiscussionaroundin-
sulin regimen change. Nevertheless,
clinic notes were consistent in explicit
documentation of the physician’s assess-
ment of awareness status. Where this was
absent, the notes were excluded. Lack of
clear documentation of insulin regimens
across all four visits also reduced the
number of records available for audit.
However, these factors should not have
operated differently between groups, and
there were no differences in demograph-
ics between included and excluded pa-
tients. Importantly, the patients were not
selected for research.
Thesedataaddaclinicaldimensionto
neuroimaging data implicating cortical
responses to hypoglycemia in generating
awareness (12). Reduced adherence to
changes in insulin regimens in hypogly-
cemia unawareness is compatible with
habituation to hypoglycemic stress, with
differences in central responses to it that
makes further exposure to the same stim-
uluslessstressful(13).Failuretoperceive
a situation as unpleasant or dangerous
subjectively undermines motivation and
ability to change behavior (14). About
half of the patients with hypoglycemia
unawareness in this audit had previously
undertaken a structured education pro-
gram proven both to reduce severe hypo-
glycemiarates(8)andrestorehypoglycemia
awareness in 48% of patients entering it
with hypoglycemia unawareness (15).
Therefore,theyarelikelytorepresentapop-
ulation for whom educational strategies
alone have failed. Behavioral strategies that
address habituation may be useful adjuncts
to educational approaches in restoring hy-
poglycemia awareness and protection
against severe hypoglycemia.
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Table 1—Subject characteristics
Hypoglycemia
unaware
Hypoglycemia
aware P
n 19 31 —
Duration of observation (days) 419  139 568  255 0.024
Age (years) 47.5  11.4 36.1  10.2 0.001
Sex (% female) 52.6 (10) 71.0 (22) 0.190
Duration type 1 diabetes (years) 32.1  12.9 20.5  11.3 0.002
Weight (kg) 70.4  16.2 73.7  13.3 0.449
BMI 25.0  5.0 26.1  4.0 0.401
% Who did not attend 7.5  11.4 12.3  12.4 0.174
% Completed DAFNE 47.4 (9) 61.3 (19) 0.336
% Psychiatric history 10.5 (2) 29.2 (7) 0.282
% Cognitive behavioral therapy 10.5 (2) 24.0 (6) 0.409
% Retinopathy (any degree on
retinal photography)* 55.6 (10) 61.3 (19) 0.694
% Nephropathy (microalbuminuria/
proteinuria)* 10.5 (2) 29.0 (9) 0.125
% Neuropathy (symptoms or
sensory loss)* 21.1 (4) 9.7 (3) 0.261
A1C (%) 7.2  0.7 8.3  1.3 0.007
Insulin dose (units   kg
1   day
1) 0.59  0.16 0.77  0.26 0.030
*Taken from annual review data during audit period. DAFNE, Dose Adjustment for Normal Eating, a 5-day
structured education program in ﬂexible insulin therapy for type 1 diabetic patients.
Smith and Associates
DIABETES CARE, VOLUME 32, NUMBER 7, JULY 2009 1197the American Diabetes Association, San Fran-
cisco, California, 6–10 June 2008.
References
1. Geddes J, Schoipman JE, Zammitt NN,
Frier BM. Prevalence of impaired aware-
ness of hypoglycaemia in adults with type
1diabetes.DiabetMed2008;25:501–504
2. CranstonI,LomasJ,MaranA,Macdonald
I, Amiel S. Restoration of hypoglycemia
awareness in patients with long-duration
insulin-dependent diabetes. Lancet 1994;
344:283–287
3. Dagago-Jack S, Rattarasan C, Cryer P. Re-
versal of hypoglycemia unawareness, but
not defective glucose counterregulation,
in IDDM. Diabetes 1994;43:1426–1434
4. Fanelli C, Epifano L, Rambotti A, Pam-
panelliS,VincenzoA,ModarelliF,Lepore
M, Annibale B, Ciofetta M, Bottini P. Me-
ticulous prevention of hypoglycemia nor-
malizes the glycemic thresholds and
magnitude of most of neuroendocrine re-
sponses to, symptoms of, and cognitive
function during hyploglycemia in inten-
sively treated patients with short-term
IDDM. Diabetes 1993;42:1983–1989
5. DAFNE Study Group. Training in ﬂexi-
ble, intensive insulin management to en-
abledietaryfreedominpeoplewithtype1
diabetes: Dose Adjustment for Normal
Eating (DAFNE) randomised controlled
trial. Br Med J 2002;325:746
6. Workgroup on Hypoglycemia, American
Diabetes Association. Deﬁning and report-
ing hypoglycemia in diabetes: a report from
the American Diabetes Association Work-
group on Hypoglycemia. Diabetes Care
2005;28:1245–1249
7. Mokan M, Mitrakou A, Veneman T, Ryan
C, Koryktowski M, Cryer P, Gerich J. Hy-
poglycemia unawareness in IDDM. Dia-
betes Care 1994;17:1397–1403
8. Bott U, Bott S, Hemmann D, Berger M.
Evaluation of a holistic treatment and
teaching programme for patients with
type1diabeteswhofailedtoachievetheir
therapeutic goals under intensiﬁed insu-
lin therapy. Diabet Med 2000;17:635–
643
9. Pickup JC, Sutton AJ. Severe hypoglycae-
mia and glycaemic control in type 1 dia-
betes: meta-analysis of multiple daily
insulin injections compared with contin-
uous subcutaneous insulin infusion. Dia-
bet Med 2008;25:765–774
10. Liu D, McManus R, Ryan E. Improved
counter-regulatory hormonal and symp-
tomatic responses to hypoglycemia in pa-
tients with insulin-dependent diabetes
mellitus after 3 months of less strict gly-
caemic control. Clin Invest Med 1996;19:
71–82
11. Clarke W, Cox D, Gonder-Frederick L,
Julian D, Schlundt D, Polonsky W. Re-
duced awareness of hypoglycemia in
IDDM adults: a prospective study of hy-
poglycemic frequency and associated
symptoms. Diabetes Care 1995;18:517–
522
12. Dunn J, Cranston I, Marsden P, Amiel S,
Reed L. Attenuation of amygdala and corti-
cal responses to low blood glucose concen-
tration in asymptomatic hypoglycemia in
type 1 diabetes. Diabetes 2007;56:2766–
2773
13. Armario A, Valles A, Dal-Zotto S, Marquez
C,BeldaX.Asingleexposuretoseverestres-
sors causes long-term desensitisation of the
physiological response to the homotypic
stressor. Stress 2004;7:157–172
14. Leventhal H, Diefenbach M, Leventhal
EA. Illness cognition: using common
sense to understand treatment adherence
and affect cognition interactions. Cogni-
tive Therapy and Research 1992;16:143–
163
15. Hopkins D, Lawrence I, Mansell P,
ThompsonG,HellerS,AmielSA.Routine
structurededucationreducesAICandhy-
poglycemia and improves psychological
health in patients with type 1 diabetes
(Abstract). Diabetes 2008;57 (Suppl. 1):
122–0R
Hypoglycemia unawareness in type 1 patients
1198 DIABETES CARE, VOLUME 32, NUMBER 7, JULY 2009